Lillian L. Siu

Dr. Lillian Siu is a senior medical oncologist at the Princess Margaret Cancer Centre and a Professor of Medicine at the University of Toronto. Dr. Siu is the Director of the Phase I Program and Co‐Director of both the Bras and Family Drug Development Program and the Tumor Immunotherapy Program at the Princess Margaret Cancer Centre.

Dr. Siu’s major research focus is in the area of new anti-cancer drug development, particularly with respect to Phase I trials and head and neck malignancies. She is the Principal Investigator of a Phase I cooperative agreement UM1 award (2014-2020) sponsored by the United States National Cancer Institute. In addition to her active research in early phase clinical trials, she has been leading genomics initiatives and immuno-oncology trials at the Princess Margaret Cancer Centre.

Dr. Siu was the recipient of the US NCI Michaele C. Christian Award in Oncology Drug Development in 2010 and has served on various committees of highly-recognized international oncology societies. Dr. Siu currently serves on the American Association for Cancer Research (AACR) Board of Directors. She has previously served on the Board of Directors for the American Society of Clinical Oncology (ASCO) and as a member of AACR’s Nomination Committee.